Human medicines European public assessment report (EPAR): Fiasp, insulin aspart, Diabetes Mellitus, Date of authorisation: 09/01/2017, Revision: 4, Status: Authorised
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):